BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 6:10:00 PM | Browse: 1208 | Download: 1129
 |
Received |
|
2012-08-31 18:59 |
 |
Peer-Review Started |
|
2012-08-31 20:11 |
 |
To Make the First Decision |
|
2012-09-24 14:50 |
 |
Return for Revision |
|
2012-11-22 10:08 |
 |
Revised |
|
|
 |
Second Decision |
|
2012-12-24 13:55 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2012-12-25 01:59 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-01-30 09:22 |
 |
Publish the Manuscript Online |
|
2013-02-06 11:36 |
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Degarelix as a new antiangiogenic agent for metastatic colon cancer?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Francois Ghiringhelli, Nicolas Isambert and Sylvain Ladoire |
Funding Agency and Grant Number |
|
Corresponding Author |
Francois Ghiringhelli, MD, PhD, Departement of Oncologie Medicale, Centre Georges Francois Leclerc, 1 rue du Professeur Marion, 21000 Dijon, France. fghiringhelli@cgfl.fr
|
Key Words |
Colon cancer; Degarelix; Chemotherapy; Angiogenesis; Antiangiogenic agents |
Core Tip |
|
Publish Date |
2013-02-06 11:36 |
Citation |
Ghiringhelli F, Isambert N, Ladoire S. Degarelix as a new antiangiogenic agent for metastatic colon cancer? World J Gastroenterol 2013; 19(5): 769-772 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i5/769.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i5.769 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345